Buy BeyondSpring Stock | BYSI Stock Price & Latest News | Public.com
BYSI

BeyondSpring

$0.00 (0.00%)Today
    View BeyondSpring (BYSI) stock trends here

    About BYSI

    BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology cancer therapies. The company's lead asset is the Plinabulin that is in late stage clinical trials as an anti-cancer agent in combination w...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.27
    -0.54
    -0.81
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.81

    Actual EPS
    Q2 2021

    Stats

    Market Cap$383,59M
    Volume89,32k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$21.50
    1 Year Low$9.55
    Open$9.80
    High$10.06
    Low$9.34

    Buy any stock with any amount of money.

    Download the App
    Download the app